New Zealand Committee on Adverse Drug Reactions. Eighth annual report.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000766:Anesthesia, Dental; D000772:Anesthesia, Local; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006801:Humans; D007223:Infant; D008297:Male; D008305:Malignant Hyperthermia / Q000139:chemically induced; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009520:New Zealand; D009638:Norepinephrine / Q000009:adverse effects; D011247:Pregnancy; D013390:Succinylcholine / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D008996:Monoamine Oxidase Inhibitors; D013390:Succinylcholine; D006221:Halothane; D009638:Norepinephrine